Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research

References

• Agustí, A., B. R. Celli, Gerard J. Criner, David Halpin, Antonio Anzueto, Peter Barnes, Jean Bourbeau, et al. 2023. “Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.” European Respiratory Journal 61 (4): 2300239. https://doi.org/10.1183/13993003.00239-2023.
   PubMed Web of Science ®Google Scholar
• Åm, H. 2019. “Limits of Decentered Governance in Science-Society Policies.” Journal of Responsible Innovation 6 (2): 163–178. https://doi.org/10.1080/23299460.2019.1605483.
   Web of Science ®Google Scholar
• Åm, H., G. Solbu, and K. H. Sørensen. 2021. “The Imagined Scientist of Science Governance.” Social Studies of Science 51 (2): 277–297. https://doi.org/10.1177/0306312720962573.
   PubMed Web of Science ®Google Scholar
• Andreasson, U. 2017. Tillid – det nordiske guld [Trust – the Nordic Gold]. Nordic Council of Ministers. https://doi.org/10.6027/ANP2017-744.
   Google Scholar
• Bajmócy, Z., and G. Pataki. 2022. Responsible Research and Innovation and the Challenges of Co-Creation, 20 [Discussion paper]. University of Szegedi, Faculty of Economics and Business Administration.
   Google Scholar
• Barnes, P. J. 2007. “Chronic Obstructive Pulmonary Disease: A Growing but Neglected Global Epidemic.” PLoS Medicine 4 (5): e112. https://doi.org/10.1371/journal.pmed.0040112.
   PubMed Web of Science ®Google Scholar
• Bauer, A., A. Bogner, and D. Fuchs. 2021. “Rethinking Societal Engagement Under the Heading of Responsible Research and Innovation: (Novel) Requirements and Challenges.” Journal of Responsible Innovation 8 (3): 342–363. https://doi.org/10.1080/23299460.2021.1909812.
   Web of Science ®Google Scholar
• Beck, U. 1992. Risk Society: Towards a New Modernity. London: SAGE Publication.
   Google Scholar
• Braun, R., and J. Starkbaum. 2023. “Stakeholders in Research and Innovation: Towards Responsible Governance.” In Putting Responsible Research and Innovation into Practice: A Multi-Stakeholder Approach, edited by V. Blok, 229–247. Springer International Publishing. https://doi.org/10.1007/978-3-031-14710-4_12
   Google Scholar
• Callon, M., and B. Latour. 1981. “Unscrewing the Big Leviathan: How Actors Macro-Structure Reality and How Sociologists Help Them to Do So.” In Advances in Social Theory and Methodology, edited by K. Knorr-Cetina and A. Cicourel, 277–303. Routledge & Kegan Paul.
   Google Scholar
• Callon, M., and V. Rabeharisoa. 2008. “The Growing Engagement of Emergent Concerned Groups in Political and Economic Life: Lessons from the French Association of Neuromuscular Disease Patients.” Science, Technology, & Human Values 33 (2): 230–261. https://doi.org/10.1177/0162243907311264.
   Web of Science ®Google Scholar
• Caulfield, T., S. H. Harmon, and Y. Joly. 2012. “Open Science Versus Commercialization: A Modern Research Conflict?” Genome Medicine 4 (2): 17. https://doi.org/10.1186/gm316.
   PubMedGoogle Scholar
• Clozel, M. 2011. “Between Confidentiality and Scientific Exchange: The Place of Publication in Drug Discovery and Pharmaceutical Research.” Science Translational Medicine 3 (67): 67cm2. https://doi.org/10.1126/scitranslmed.3001890.
   PubMed Web of Science ®Google Scholar
• Cohen, J. B. 2022. “Institutionalizing Public Engagement in Research and Innovation: Toward the Construction of Institutional Entrepreneurial Collectives.” Science and Public Policy 49 (5): 673–685. https://doi.org/10.1093/scipol/scac018.
   Web of Science ®Google Scholar
• Cohen, J. B., and R. Gianni. 2023. “Democratic Experimentation with Responsibility: A Pragmatist Approach to Responsible Research and Innovation.” In Putting Responsible Research and Innovation into Practice: A Multi-Stakeholder Approach, edited by V. Blok, 57–77. Springer International Publishing. https://doi.org/10.1007/978-3-031-14710-4_4.
   Google Scholar
• Davies, S. R., C. Glerup, and M. Horst. 2014. “On Being Responsible: Multiplicity in Responsible Development.” In Responsibility in Nanotechnology Development, edited by S. Arnaldi, A. Ferrari, P. Magaudda, and F. Marin, vol. 13, 143–159. Springer. https://doi.org/10.1007/978-94-017-9103-8_9.
   Google Scholar
• Davies, S. R., and K. Lindvig. 2021. “Assembling Research Integrity: Negotiating a Policy Object in Scientific Governance.” Critical Policy Studies, 1–18. https://doi.org/10.1080/19460171.2021.1879660.
   Web of Science ®Google Scholar
• de Saille, S. 2015. “Innovating Innovation Policy: The Emergence of ‘Responsible Research and Innovation’.” Journal of Responsible Innovation 2 (2): 152–168. https://doi.org/10.1080/23299460.2015.1045280.
   Web of Science ®Google Scholar
• Fazleen, A., and T. Wilkinson. 2020. “Early COPD: Current Evidence for Diagnosis and Management.” Therapeutic Advances in Respiratory Disease 14: 1753466620942128. https://doi.org/10.1177/1753466620942128.
   Web of Science ®Google Scholar
• Felt, U. 2017. “‘Responseable Practices’ or ‘New Bureaucracies of Virtue’: The Challenges of Making RRI Work in Academic Environments.” In Responsible Innovation 3: A European Agenda?, edited by L. Asveld, R. van Dam-Mieras, T. Swierstra, S. Lavrijssen, K. Linse, and J. van den Hoven, 49–68. Springer International Publishing. https://doi.org/10.1007/978-3-319-64834-7_4.
   Google Scholar
• Fordham, A. E., and G. M. Robinson. 2018. “Mapping Meanings of Corporate Social Responsibility – an Australian Case Study.” International Journal of Corporate Social Responsibility 3 (1): 14. https://doi.org/10.1186/s40991-018-0036-1.
   Google Scholar
• Frahm, N., T. Doezema, and S. Pfotenhauer. 2022. “Fixing Technology with Society: The Coproduction of Democratic Deficits and Responsible Innovation at the OECD and the European Commission.” Science, Technology, & Human Values 47 (1): 174–216. https://doi.org/10.1177/0162243921999100.
   Web of Science ®Google Scholar
• Garst, J., V. Blok, L. Jansen, and O. S. W. F. Omta. 2017. “Responsibility Versus Profit: The Motives of Food Firms for Healthy Product Innovation.” Sustainability 9 (12): 12. https://doi.org/10.3390/su9122286.
   Web of Science ®Google Scholar
• Gerber, A., E.-M. Forsberg, Clare Shelley-Egan, Rosa Arias, Stephanie Daimer, Gordan Dalton, Ana Belén Cristóbal, et al. 2020. “Joint Declaration on Mainstreaming RRI Across Horizon Europe.” Journal of Responsible Innovation 7 (3): 708–711. https://doi.org/10.1080/23299460.2020.1764837.
   Web of Science ®Google Scholar
• Glerup, C., S. R. Davies, and M. Horst. 2017. “‘Nothing Really Responsible Goes on Here’: Scientists’ Experience and Practice of Responsibility.” Journal of Responsible Innovation 4 (3): 319–336. https://doi.org/10.1080/23299460.2017.1378462.
   Web of Science ®Google Scholar
• Glerup, C., and M. Horst. 2014. “Mapping ‘Social Responsibility’ in Science.” Journal of Responsible Innovation 1 (1): 31–50. https://doi.org/10.1080/23299460.2014.882077.
   Google Scholar
• Gurzawska, A., M. Mäkinen, and P. Brey. 2017. “Implementation of Responsible Research and Innovation (RRI) Practices in Industry: Providing the Right Incentives.” Sustainability 9 (10): 10. https://doi.org/10.3390/su9101759.
   Web of Science ®Google Scholar
• Hågvar, Y. B., and J. Alnæs. 2020. “Help Yourself: The Individualization of Responsibility in Current Health Journalism.” In Media Health, 23–50. Universitetsforlaget. https://doi.org/10.18261/9788215040844-2020-3.
   Google Scholar
• Hjorth, R., L. van Hove, and F. Wickson. 2017. “What Can Nanosafety Learn from Drug Development? The Feasibility of “Safety by Design”.” Nanotoxicology 11 (3): 305–312. https://doi.org/10.1080/17435390.2017.1299891.
   PubMed Web of Science ®Google Scholar
• Hughes, J., S. Rees, S. Kalindjian, and K. Philpott. 2011. “Principles of Early Drug Discovery.” British Journal of Pharmacology 162 (6): 1239–1249. https://doi.org/10.1111/j.1476-5381.2010.01127.x.
   PubMed Web of Science ®Google Scholar
• Hulsen, T. 2020. “Sharing is Caring-Data Sharing Initiatives in Healthcare.” International Journal of Environmental Research and Public Health 17 (9): 3046. https://doi.org/10.3390/ijerph17093046.
   PubMed Web of Science ®Google Scholar
• Irwin, A. 2001. “Constructing the Scientific Citizen: Science and Democracy in the Biosciences.” Public Understanding of Science 10 (1): 1–18. https://doi.org/10.3109/a036852.
   Web of Science ®Google Scholar
• Irwin, A. 2006. “The Politics of Talk: Coming to Terms with the ‘New’ Scientific Governance.” Social Studies of Science 36 (2): 299–320. https://doi.org/10.1177/0306312706053350.
   Web of Science ®Google Scholar
• Irwin, A., and B. Wynne. 1996. Misunderstanding Science?: The Public Reconstruction of Science and Technology. Cambridge: Cambridge University Press.
   Google Scholar
• Jasanoff, S. 2003. “Technologies of Humility: Citizen Participation in Governing Science.” Minerva 41: 223–244. https://doi.org/10.1023/A:1025557512320.
   Web of Science ®Google Scholar
• Jasanoff, S., ed., 2004. States of Knowledge: The Co-Production of Science and the Social Order, 1st ed. London: Taylor and Francis.
   Google Scholar
• Joly, P.-B., and A. Kaufmann. 2008. “Lost in Translation? The Need for ‘Upstream Engagement’ with Nanotechnology on Trial.” Science as Culture 17 (3): 225–247. https://doi.org/10.1080/09505430802280727.
   Google Scholar
• Karner, S., Z. Bajmócy, M. Deblonde, B. Balázs, G. Pataki, M. Racovita, A. Snick, A. Thaler, and M. Wicher. 2016. RRI Concepts, Practices, Barriers and Potential Levers.
   Google Scholar
• Klug, D. M., F. I. M. Idiris, M. A. T. Blaskovich, F. von Delft, C. G. Dowson, C. Kirchhelle, A. P. Roberts, A. C. Singer, and M. H. Todd. 2021. “There is no Market for New Antibiotics: This Allows an Open Approach to Research and Development.” Wellcome Open Research 6: 146. https://doi.org/10.12688/wellcomeopenres.16847.1.
   PubMedGoogle Scholar
• Kwee, Z., E. Yaghmaei, and S. Flipse. 2021. “Responsible Research and Innovation in Practice an Exploratory Assessment of Key Performance Indicators (KPIs) in a Nanomedicine Project.” Journal of Responsible Technology 5: 100008. https://doi.org/10.1016/j.jrt.2021.100008.
   Google Scholar
• Luhmann, N. 1999. Tillid: En mekanisme til reduktion af social kompleksitet [Trust: A Mechanism for the Reduction of Social Complexity]. Copenhagen: Hans Reitzels Forlag.
   Google Scholar
• Mathioudakis, A. G., S. Ananth, and J. Vestbo. 2021. “Stigma: An Unmet Public Health Priority in COPD.” The Lancet Respiratory Medicine 9 (9): 955–956. https://doi.org/10.1016/S2213-2600(21)00316-7.
   PubMed Web of Science ®Google Scholar
• Michali, M., and G. Eleftherakis. 2022. “Public Engagement Practices in EC-Funded RRI Projects: Fostering Socio-Scientific Collaborations.” Administrative Sciences 12 (3): 3. https://doi.org/10.3390/admsci12030104.
   Web of Science ®Google Scholar
• Navon, D., and G. Eyal. 2016. “Looping Genomes: Diagnostic Change and the Genetic Makeup of the Autism Population.” American Journal of Sociology 121 (5): 1416–1471. https://doi.org/10.1086/684201.
   PubMed Web of Science ®Google Scholar
• Owen, R., R. von Schomberg, and P. Macnaghten. 2021. “An Unfinished Journey? Reflections on a Decade of Responsible Research and Innovation.” Journal of Responsible Innovation 8 (2): 217–233. https://doi.org/10.1080/23299460.2021.1948789.
   Web of Science ®Google Scholar
• Porcari, A., D. Pimponi, E. Borsella, P. Klaassen, M. J. Maia, and E. Mantovani. 2020. “Supporting RRI Uptake in Industry: A Qualitative and Multi-Criteria Approach to Analysing the Costs and Benefits of Implementation.” In Assessment of Responsible Innovation: Methods and Practices, 1st ed. London: Routledge.
   Google Scholar
• Rach, C., J. Lukas, R. Müller, M. Sendler, P. Simon, and S. Salloch. 2020. “Involving Patient Groups in Drug Research: A Systematic Review of Reasons.” Patient Preference and Adherence 14: 587–597. https://doi.org/10.2147/PPA.S232499.
   PubMed Web of Science ®Google Scholar
• Ribeiro, B., L. Bengtsson, Paul Benneworth, Susanne Bührer, Elena Castro-Martínez, Meiken Hansen, Katharina Jarmai, et al. 2018. “Introducing the Dilemma of Societal Alignment for Inclusive and Responsible Research and Innovation.” Journal of Responsible Innovation 5 (3): 316–331. https://doi.org/10.1080/23299460.2018.1495033.
   Web of Science ®Google Scholar
• Ribeiro, B. E., R. D. J. Smith, and K. Millar. 2017. “A Mobilising Concept? Unpacking Academic Representations of Responsible Research and Innovation.” Science and Engineering Ethics 23 (1): 81–103. https://doi.org/10.1007/s11948-016-9761-6.
   PubMed Web of Science ®Google Scholar
• Roy, V. 2020. “A Crisis for Cures? Tracing Assetization and Value in Biomedical Innovation.” In Assetization: Turning Things Into Assets in Technoscientific Capitalism, edited by K. Birch and F. Muniesa, 89–116. Cambridge: MIT press.
   Google Scholar
• Sheikh, Z. A., and K. Hoeyer. 2018. “That is Why I Have Trust”: Unpacking What ‘Trust’ Means to Participants in International Genetic Research in Pakistan and Denmark.” Medicine, Health Care and Philosophy 21 (2): 169–179. https://doi.org/10.1007/s11019-017-9795-9.
   PubMed Web of Science ®Google Scholar
• Shore, C., S. Wright, and D. Però. 2011. Policy Worlds: Anthropology and the Analysis of Contemporary Power. New York: Berghahn Books.
   Google Scholar
• Sideri, K., and B. Prainsack. 2023. “COVID-19 Contact Tracing Apps and the Governance of Collective Action: Social Nudges, Deliberation, and Solidarity in Europe and Beyond.” Policy Studies 44 (1): 132–153. https://doi.org/10.1080/01442872.2022.2130884.
   Web of Science ®Google Scholar
• Sinha, S., and D. Vohora. 2018. “Chapter 2 - Drug Discovery and Development: An Overview.” In Pharmaceutical Medicine and Translational Clinical Research, edited by D. Vohora and G. Singh, 19–32. Academic Press. https://doi.org/10.1016/B978-0-12-802103-3.00002-X.
   Google Scholar
• Timmermans, J., V. Blok, R. Braun, R. Wesselink, and R. Ø. Nielsen. 2020. “Social Labs as an Inclusive Methodology to Implement and Study Social Change: The Case of Responsible Research and Innovation.” Journal of Responsible Innovation 7 (3): 410–426. https://doi.org/10.1080/23299460.2020.1787751.
   Web of Science ®Google Scholar
• van Hove, L., and F. Wickson. 2017. “Responsible Research is not Good Science: Divergences Inhibiting the Enactment of RRI in Nanosafety.” Nanoethics 11 (3): 213–228. https://doi.org/10.1007/s11569-017-0306-5.
   Web of Science ®Google Scholar
• van Oudheusden, M. 2014. “Where are the Politics in Responsible Innovation? European Governance, Technology Assessments, and Beyond.” Journal of Responsible Innovation 1 (1): 67–86. https://doi.org/10.1080/23299460.2014.882097.
   Google Scholar
• Wadmann, S. 2014. “Physician–Industry Collaboration: Conflicts of Interest and the Imputation of Motive.” Social Studies of Science 44 (4): 531–554. https://doi.org/10.1177/0306312714525678.
   PubMed Web of Science ®Google Scholar
• Wang, X., S. Zhang, Y. Liu, J. Du, and H. Huang. 2021. “How Pharmaceutical Innovation Evolves: The Path from Science to Technological Development to Marketable Drugs.” Technological Forecasting and Social Change 167: 120698. https://doi.org/10.1016/j.techfore.2021.120698.
   Web of Science ®Google Scholar
• Wittrock, C., E. M. Forsberg, A. Pols, P. Macnaghten, and D. Ludwig. 2021. Implementing Responsible Research and Innovation: Organisational and National Conditions, 120. Cham: Springer Nature.
   Google Scholar
• Wouters, O. J., M. McKee, and J. Luyten. 2020. “Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009–2018.” JAMA 323 (9): 844–853. https://doi.org/10.1001/jama.2020.1166.
   PubMed Web of Science ®Google Scholar
• Wynne, B. 2006. “Public Engagement as a Means of Restoring Public Trust in Science – Hitting the Notes, but Missing the Music?” Public Health Genomics 9 (3): 211–220. https://doi.org/10.1159/000092659.
   Web of Science ®Google Scholar
• Yu, H. 2019. “Responsible Research and Innovation and the Advancement of Biobanking and Biomedical Research.” In Global Genes, Local Concerns, edited by T. Minssen, J. Herrmann, and J. Schovsbo, 186–215. Edward Elgar Publishing. https://doi.org/10.4337/9781788116190.00020.
   Google Scholar
• Zwart, H., L. Landeweerd, and A. van Rooij. 2014. “Adapt or Perish? Assessing the Recent Shift in the European Research Funding Arena from ‘ELSA’ to ‘RRI’.” Life Sciences, Society and Policy 10 (1): 11. https://doi.org/10.1186/s40504-014-0011-x.
   PubMedGoogle Scholar